Edition:
United States

People: Amgen Inc (AMGN.O)

AMGN.O on Nasdaq

154.60USD
24 May 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$154.60
Open
$154.77
Day's High
$154.99
Day's Low
$153.79
Volume
2,669,558
Avg. Vol
3,617,601
52-wk High
$184.21
52-wk Low
$133.64

Harper, Sean 

Dr. Sean E. Harper is the Executive Vice President - Research and Development of Amgen Inc. Dr. Harper joined the Company in 2002, and has held leadership roles in early development, medical sciences and global regulatory and safety. Dr. Harper served as Senior Vice President, Global Development and Corporate Chief Medical Officer from March 2007 to February 2012. Prior to joining the Company, Dr. Harper worked for five years at Merck Research Laboratories.

Basic Compensation

Total Annual Compensation, USD 946,246
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 5,266,800
Fiscal Year Total, USD 6,213,040

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 8,000 447,070.00
Name Fiscal Year Total

Robert Bradway

16,850,000

David Meline

6,218,460

Sean Harper

6,213,040

Anthony Hooper

6,965,180

Brian McNamee

--

Esteban Santos

--
As Of  30 Dec 2016